Understanding How Swedish Gastric Band Weight Loss Surgery Works
The Swedish Adjustable Gastric Band, abbreviated SAGB, was first developed in 1985 by Swedish researchers. This procedure has been available to obese patients around the world since 1996. SAGB is a restrictive surgical procedure that involves a soft band being placed around the upper stomach area. The surgery has been described as placing a belt around the stomach to shrink the size of the stomach. This procedure divides the stomach into two separate areas. The band is tightened until only a small opening between the two areas that allows food to slowly pass through the lower stomach and into the digestive tract. Because the upper stomach is small, patients experience fullness quickly, causing them to eat less.
What Are the Advantages of the Swedish Adjustable Gastric Band?
- The SAGB procedure helps patients consume less food at meal time.
- Food passes through your digestive tract, ensuring that that your body receives the nutrients it needs.
- The SAGB procedure can be done laparoscopically.
- The band can be adjusted to increase the size of the pouch.
SAGB is completely reversible.
- Approximately 50 to 60 percent of the patient’s weight loss is realized during the first two years. In fact, most weight loss occurs during the first twelve months.
- Because the procedure only decreases the amount of food the patient eats, no nutritional supplements are required.
- Many patients experience improvement or reversal of obesity related diseases, including sleep apnea, stroke, cardiovascular disease, high blood pressure, fertility issues, type 2 diabetes and arthritis. Additionally, as most patients begin losing weight, their outlook on life becomes more positive, their self-confidence improves and their psychological impacts are positive.
- SAGB offers faster recovery times than some of the other weight loss procedures.
Swedish Gastric Band weight loss surgery helps patients around the world lose weight and begin enjoying life again. This weight loss procedure has been available to those who are morbidly obese for more than 40 years.